Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

PBMD

Immutep Limited (PBMD)

Immutep Limited
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:PBMD
DatumZeitQuelleÜberschriftSymbolFirma
23/02/201812h09Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
09/02/201814h00Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
02/02/201815h03Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
23/01/201812h04Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
26/12/201716h02Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
21/12/201712h55Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
13/12/201712h03Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
05/12/201712h10Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
01/12/201712h07Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
28/11/201701h12GlobeNewswire Inc.Prima BioMed Becomes ImmutepNASDAQ:PBMDImmutep Limited
24/11/201716h10Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
22/11/201712h06Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
22/11/201700h07GlobeNewswire Inc.Prima Secures European Patent Grant for Lead Product IMP321 in CancerNASDAQ:PBMDImmutep Limited
21/11/201712h04Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
20/11/201716h03Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
20/11/201716h01Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
20/11/201707h59GlobeNewswire Inc.Prima BioMed Changes Its Name to Immutep LtdNASDAQ:PBMDImmutep Limited
16/11/201712h03Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
15/11/201709h11GlobeNewswire Inc.Eftilagimod Alpha (LAG-3Ig Or IMP321) Pre-IND Meeting With the FDANASDAQ:PBMDImmutep Limited
09/11/201723h29Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
08/11/201723h45GlobeNewswire Inc.New Eftilagimod Alpha (LAG-3Ig or IMP321) Data for Presentation at the Society for Immunotherapy of Cancer (SITC) 2017 Annual...NASDAQ:PBMDImmutep Limited
03/11/201711h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PBMDImmutep Limited
01/11/201712h28Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
01/11/201700h15GlobeNewswire Inc.Dr. Frédéric Triebel Presented at the World Immunotherapy Congress 2017NASDAQ:PBMDImmutep Limited
20/10/201723h06Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
20/10/201722h58Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
20/10/201705h23GlobeNewswire Inc.Dr. Frédéric Triebel Presenting at the World Immunotherapy Congress 2017NASDAQ:PBMDImmutep Limited
19/10/201722h41Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:PBMDImmutep Limited
19/10/201722h39Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:PBMDImmutep Limited
18/10/201712h04Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
 Showing the most relevant articles for your search:NASDAQ:PBMD